Development of a Pharmacokinetic/Pharmacodynamic Model of Dexmedetomidine, and the Effect of Repeated Auditory Stimulation on Pharmacodynamics of Dexmedetomidine.
Phase of Trial: Phase II
Latest Information Update: 26 Aug 2015
Price : $35 *
At a glance
- Drugs Dexmedetomidine (Primary)
- Indications Anxiety disorders; Pain
- Focus Pharmacodynamics; Pharmacokinetics
- 15 Oct 2013 Planned End Date changed from 1 Dec 2013 to 1 Nov 2013 as reported by ClinicalTrials.gov.
- 03 Jul 2013 New trial record